/> ShareJunction - Member Posts
logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Stock Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Back

Latest Posts By Peter_Pan - Supreme      About Peter_Pan
First   < Newer   1801-1820 of 4497   Older>   Last  

08-Aug-2013 11:31 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		Biotechnology company Biosensors’ (SGX: B20) reported an 11% decline in first-quarter sales to US$76.7m. Profits fell some 63% to US$12.1m.

The company’s main business activity lies in the manufacture of various types of drug-eluting stents (DES), which are medical device used to unclog blocked arteries. The company splits its revenue into four segments, namely, Critical Care, Interventional Cardiology, Cardiac Diagnostic and Licensing & Royalties.

Biosensor’s top-line decline was mainly due to a drop in revenues from Interventional Cardiology and Licensing & Royalties, both of which are the main revenue drivers for the company. The former made up 79% of the company’s total sales while the latter accounted for 17%.

Interventional Cardiology’s sales for the quarter slid 7.3% to US$60.9m from a year ago mainly due to a slowdown in DES sales in China. That in turn, was the result of the company’s intentional reduction in the inventory levels of distributors in China because of “on-going and upcoming tender activities.”

The company’s other DES markets in the Europe, Middle East & Africa (EMEA) and Asia Pacific regions all saw “strong, double-digit sales growth.”

Licensing & Royalties revenue, where Biosensors licenses its DES technology to others, was down by 32.7% to US$11.6m. Critical Care brought in US$3.43m in sales, up a smidgen from US$3.34m in the previous year.

Finally, Cardiac Diagnostic had US$706,000 in sales for the quarter. It is a new segment for Biosensors, and is the result of a consolidation of Spectrum Dynamics’ business. Spectrum Dynamics is a company that does cardiac imaging systems and was acquired by Biosensors for US$51m in May this year.

Biosensor’s CEO, Dr Jack Wang, had this to say regarding the acquisition: “The integration process of our recently acquired business, [Spectrum Dynamics], is well on track. We are excited about the recent Japanese regulatory approval of its D-SPECT system and we remain confident of our ability to unlock the potential of this business.”

The company’s profits fell proportionately more than the decline in revenues which suggests a compression in net profit margins. There are three reasons for this.

Firstly, gross margins fell from 85% to 79%. Biosensors had entered into an agreement with Terumo Corporation in Japan to distribute Nobori DES last year and the distribution activity this quarter was one of the reasons for the fall in gross margins.

The consolidation of Spectrum Dyanmics’ businesses also ate into Biosensor’s gross profits as Cardiac Diagnostics carry inherently lower margins.

Secondly, Biosensor had spent US$26.6m on sales & marketing expenses for the quarter, an increase of 19.3% from a year ago.

Finally, there was a 121% year-on-year increase in interest expenses to US$3.4m. The increase was mainly due to US$240m worth of debt that Biosensors issued on Jan 2013. Those loans are due for repayment after four years and carry an interest rate of 4.875% per year.

The three reasons were the main causes for Biosensor’s lower net profit margins.

Biosensors’ balance sheet remains robust with a total debt load of US$273m and a cash hoard worth US$546m. The company is satisfied with the amount of cash on hand and with “continued improvement in [its] operating performance” in the horizon, there are no plans currently for future fund raising activities.

The company has forecast a 15% year-on-year growth in revenues for the year. It expects sales continuing to climb in the EMEA and Asia Pacific regions and it is confident that DES sales in China will pick up in rest of the year. In addition, Biosensors also expects the Spectrum Dynamics acquisition to provide new markets for the company.

Shares of Biosensors closed at S$0.975 on Wednesday, which represents a trailing price-to-earnings ratio of 14 and a dividend yield of 2.6% based on last year’s full-year pay-out.
Good Post  Bad Post 
08-Aug-2013 11:27 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		MEDICAL device manufacturer Biosensors Group International announced a 63 per cent fall in net profit to US$12.1 million (S$15.3 million) for its first quarter ended June 30.
Lower profit was due to a combination of lower revenue, higher cost of sales and higher sales and marketing expenses.
Revenue was down 11 per cent to US$76.7 million.
The group is guiding for revenue for the fiscal year ending Mar 31, 2014, to grow by 15 per cent, driven by growth for drug-eluting stent sales and an expectation that China sales will recover.
Good Post  Bad Post 
07-Aug-2013 21:47 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		May either rebound or drop next week. 0.96 must hold, if not
Good Post  Bad Post 
07-Aug-2013 18:51 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		Monday may either rebound or drop further.

Biosensor = Dr Quack

junction      ( Date: 07-Aug-2013 18:41) Posted:

got kelong directors.  Useless bunch who don't deserve their directors fees.

Peter_Pan      ( Date: 07-Aug-2013 18:36) Posted:

Still profitable but net profit plunged 68% qoq. Hope for a rebound.
Good Post  Bad Post 
07-Aug-2013 18:43 Neptune Orient L Rg   /   NOL       Go to Message
x 0
x 0 		Should see NOL go above 1.10 soon.
Good Post  Bad Post 
07-Aug-2013 18:36 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		Still profitable but net profit plunged 68% qoq. Hope for a rebound.
Good Post  Bad Post 
07-Aug-2013 16:11 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		Will be reporting results today. Think to
Good Post  Bad Post 
07-Aug-2013 16:09 Biosensors   /   Is Biosensors a good buy?       Go to Message
x 0
x 0 		Hope to see a rebound soon.
Good Post  Bad Post 
07-Aug-2013 15:36 YZJ Shipbldg SGD   /   Cruising with the ship ..Yangzijiang       Go to Message
x 0
x 0 		Last one standing - OUTPERFORM - Upgrade - TP S$1.25 - CIMB
Good Post  Bad Post 
07-Aug-2013 09:51 Vard   /   Vard Holdings       Go to Message
x 0
x 0 		Still cheap.

Peter_Pan      ( Date: 06-Aug-2013 21:33) Posted:

0.90 is a given.
Good Post  Bad Post 
06-Aug-2013 21:40 ThaiBev   /   up or down on debut?       Go to Message
x 0
x 0 		This long weekend enjoy Chang Beer and Gold Label!!!

Shortists BBs can also enjoy...but can only enjoy Orh Bak Kak Label...MUahHaHaHaHaa!!!
Good Post  Bad Post 
06-Aug-2013 21:33 Vard   /   Vard Holdings       Go to Message
x 0
x 0 		0.90 is a given.
Good Post  Bad Post 
06-Aug-2013 10:04 ThaiBev   /   up or down on debut?       Go to Message
x 0
x 0 		Shortists BBs drank Orh Bak Kak Label...
Good Post  Bad Post 
06-Aug-2013 09:56 ThaiBev   /   up or down on debut?       Go to Message
x 0
x 0 		Spirits do not scare us - OUTPERFORM - TP S$0.74 - CIMB
Good Post  Bad Post 
06-Aug-2013 09:50 Vard   /   Vard Holdings       Go to Message
x 0
x 0 		Hard Times In Brazil But 2Q13 Could Be Bottom - BUY - TP $1.10 - DMG
Good Post  Bad Post 
05-Aug-2013 14:16 Golden Agri-Res   /   GoldenAgr       Go to Message
x 0
x 0 		Have touched my 0.51 target. Breaking 0.50 will be
Good Post  Bad Post 
05-Aug-2013 14:01 Golden Agri-Res   /   GoldenAgr       Go to Message
x 0
x 0 		Golden Agri-Resources – UOBKH has a Technical SELL with +11.7% potential return
Good Post  Bad Post 
05-Aug-2013 13:56 Golden Agri-Res   /   GoldenAgr       Go to Message
x 0
x 0 		Shares in Golden Agri-Resources Ltd  fell as much 
as 2.9 percent to S$0.51, the lowest since July 2010, after the 
company posted a 58 percent fall in second-quarter net profit. 
It was the second-highest traded stock by value in Singapore. 
OCBC Investment Research sees a muted outlook for crude palm 
oil prices as global demand, especially out of China and India, 
remains weak and supply is expected to increase in the second 
half of the year. 
OCBC slashed its core earnings estimate for Golden Agri's 
2013 fiscal year by 19 percent to account for increased margin 
pressure. It downgraded the stock to " sell" from " hold" and cut 
its target price to S$0.465 from S$0.57.
Good Post  Bad Post 
05-Aug-2013 11:18 Golden Agri-Res   /   GoldenAgr       Go to Message
x 0
x 0 		Golden Agri Resources: Rising costs, lower yields. DBS Vickers lowered DCF Valuation to $0.45
Good Post  Bad Post 
05-Aug-2013 10:05 Golden Agri-Res   /   GoldenAgr       Go to Message
x 0
x 0 		Downgrade to SELL- poor 2Q13 showing - SELL - TP $0.465 - OCBC Research

Peter_Pan      ( Date: 03-Aug-2013 12:21) Posted:

May touch 0.51 next week and subsequently breaks 0.50

New123      ( Date: 03-Aug-2013 12:14) Posted:

current price has already bn factored in this result. going forward cpo prices may stabilize and move up..


Good Post  Bad Post 
First   < Newer   1801-1820 of 4497   Older>   Last  



ShareJunction Version: 27 Nov 2020 ver - All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.